BIOXCEL THERAPEUTICS INC (BTAI) Stock Earnings & Estimates
USA - NASDAQ:BTAI - US09075P2048 - Common Stock
1.61 USD
-0.1 (-5.85%)
1.63 USD
+0.02 (+1.24%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 380K | 1.38M 263.16% | 2.266M 64.20% | 731.952K -67.70% | 4.721M 544.99% | 76.49M 1,520.21% | 99.43M 29.99% | 170.04M 71.01% | 92.983M -45.32% | 137.82M 48.22% | 208.05M 50.96% | |
| EBITDA YoY % growth | -159.32M -49.40% | -167.301M -5.01% | -64.495M 61.45% | -51.891M 19.54% | -58.001M -11.77% | -41.412M 28.60% | -55.896M -34.98% | -8.109M 85.49% | 1.734M 121.38% | 40.086M 2,211.76% | 101.18M 152.41% | |
| EBIT YoY % growth | -159.65M -49.29% | -167.619M -4.99% | -64.804M 61.34% | -50.987M 21.32% | -49.623M 2.68% | -42.238M 14.88% | -56.457M -33.66% | -8.772M 84.46% | 1.326M 115.12% | 39.372M 2,869.23% | 100.06M 154.14% | |
| Operating Margin | -42,013.16% | -12,146.30% | -2,859.84% | -6,965.94% | -1,051.11% | -55.22% | -56.78% | -5.16% | 1.43% | 28.57% | 48.09% | |
| EPS YoY % growth | -94.59 -44.90% | -98.40 -4.03% | -25.97 73.61% | -5.60 78.42% | -4.01 28.36% | -0.94 76.63% | -1.01 -7.61% | 0.83 181.82% | 2.69 225.93% | N/A | N/A |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.77 78.57% | -0.75 49.91% | -0.78 68.36% | -0.94 57.11% | -0.77 -0.89% |
| Revenue Q2Q % growth | 255K -30.33% | 255K 51.79% | 255K 112.50% | 306K 206.00% | 459K 80.00% |
| EBITDA Q2Q % growth | -11.954M -17.75% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -10.5M -0.37% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -2.18 57.42% | -1.20 | -0.98 | -81.51% |
| Q2 2025 Q2Q % growth | -2.45 27.08% | -1.89 | -0.56 | -29.42% |
| Q1 2025 Q2Q % growth | -1.50 89.22% | -6.79 | 5.29 | 77.91% |
| Q4 2024 Q2Q % growth | -3.57 70.64% | -6.55 | 2.98 | 45.53% |
| Q3 2024 Q2Q % growth | -5.12 81.40% | -8.84 | 3.72 | 42.08% |
| Q2 2024 Q2Q % growth | -3.36 88.52% | -11.59 | 8.23 | 71.00% |
| Q1 2024 Q2Q % growth | -13.92 52.72% | -11.40 | -2.52 | -22.14% |
| Q4 2023 Q2Q % growth | -12.16 61.03% | -14.85 | 2.69 | 18.12% |
| Q3 2023 Q2Q % growth | -27.52 -15.28% | -21.28 | -6.24 | -29.32% |
| Q2 2023 Q2Q % growth | -29.28 -35.56% | -28.57 | -0.71 | -2.47% |
| Q1 2023 Q2Q % growth | -29.44 -64.29% | -26.41 | -3.03 | -11.48% |
| Q4 2022 Q2Q % growth | -31.20 -109.68% | -23.60 | -7.60 | -32.18% |
| Q3 2022 Q2Q % growth | -23.87 -55.42% | -22.03 | -1.84 | -8.35% |
| Q2 2022 Q2Q % growth | -21.60 -21.62% | -19.90 | -1.70 | -8.57% |
| Q1 2022 Q2Q % growth | -17.92 -3.70% | -18.71 | 0.79 | 4.24% |
| Q4 2021 Q2Q % growth | -14.88 -6.90% | -18.02 | 3.14 | 17.41% |
| Q3 2021 Q2Q % growth | -15.36 10.28% | -17.15 | 1.79 | 10.45% |
| Q2 2021 Q2Q % growth | -17.76 -4.72% | -17.71 | -0.05 | -0.30% |
| Q1 2021 Q2Q % growth | -17.28 -36.71% | -15.32 | -1.96 | -12.79% |
| Q4 2020 Q2Q % growth | -13.92 -93.33% | -15.62 | 1.70 | 10.87% |
| Q3 2020 Q2Q % growth | -17.12 -87.72% | -13.04 | -4.08 | -31.31% |
| Q2 2020 Q2Q % growth | -16.96 -96.30% | -12.22 | -4.74 | -38.77% |
| Q1 2020 Q2Q % growth | -12.64 -71.74% | -9.71 | -2.93 | -30.17% |
| Q4 2019 Q2Q % growth | -7.20 | -10.34 | 3.14 | 30.34% |
| Q3 2019 Q2Q % growth | -9.12 | -10.55 | 1.43 | 13.58% |
| Q2 2019 Q2Q % growth | -8.64 | -9.86 | 1.22 | 12.35% |
| Q1 2019 Q2Q % growth | -7.36 | -8.92 | 1.56 | 17.50% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 100K -53.27% | 216.75K | -116.75K | -53.86% |
| Q2 2025 Q2Q % growth | 120K -89.13% | 255K | -135K | -52.94% |
| Q1 2025 Q2Q % growth | 168K -71.13% | 435.203K | -267.203K | -61.40% |
| Q4 2024 Q2Q % growth | 366K -2.66% | 720.803K | -354.803K | -49.22% |
| Q3 2024 Q2Q % growth | 214K -37.24% | 1.332M | -1.118M | -83.93% |
| Q2 2024 Q2Q % growth | 1.104M 141.58% | 774.384K | 329.616K | 42.56% |
| Q1 2024 Q2Q % growth | 582K 182.52% | 473.28K | 108.72K | 22.97% |
| Q4 2023 Q2Q % growth | 376K 56.67% | 725.353K | -349.353K | -48.16% |
| Q3 2023 Q2Q % growth | 341K 143.57% | 673.2K | -332.2K | -49.35% |
| Q2 2023 Q2Q % growth | 457K | 462.968K | -5.968K | -1.29% |
| Q1 2023 Q2Q % growth | 206K | 509.072K | -303.072K | -59.53% |
| Q4 2022 Q2Q % growth | 240K | 1.273M | -1.033M | -81.15% |
| Q3 2022 Q2Q % growth | 140K | 1.116M | -976K | -87.46% |
| Q1 2022 Q2Q % growth | 127.5K | -127.5K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 4.73% | 24.76% | -3.53% | 20.09% |
| Revenue | -1.62% | -39.29% | -7.57% | -49.17% |